EB Senior Hiring Surge
Roger Altman: "Evercore just completed the largest, external hiring surge, at the SMD level, in the Firm’s history. And, this came on top of aggressive hiring in each recent year, which means that our productive capacity is at an all-time high." (link)
Paul Taubman: “PJT has accelerated the pace of our senior hiring... 2023 shaping up to be our most consequential hiring year ever .... We will continue to invest to enhance our franchise and we remain highly confident in our future growth prospects." (link)
Both of these comments came from the last week.
- Is this an aggressive and excessively risky bet from two firms that are known for giving shrewd/conservative advice - at a time when deal activity is in the toilet? Or a smart move ahead of a major pick-up in volume in the coming 12 months?
- Is the long-standing trend of EBs taking share from BBs on the most lucrative and complex situations going to accelerate over the coming years?
- Are lay-offs or shrinking bonuses at EBs inevitable as a way of paying for all this senior talent, many of whom received two-year guarentees of base comp of $1-2m+?
Discuss
Why do all you summer associates want to make everything a business school case study...Bunch of seniors are getting fired across the board so boutiques are just leveraging that opportunity to hire well-connected MDs...ffs.
You can't just answer my mans question without being an ass?
I swear they make things more complicated than it needs to be lol.
All good. I am completely aware that I lack IB knowhow and experience. And I totally understand why other bankers, especially Analysts, find MBA associates to unsufferable, low impact morons.. but just curious about what I'm reading and figured others might be as well
not only EBs. Jefferies added 60+ managing directors this year. DB, Santander and Mizuho added lots of headcount too.
Shit's gonna hit the fan at these places if the deal environment doesn't pick back up again soon.
PJT just had a record quarter of off RX
Ya, and most of the new hires are in M&A / Advisory. Don't think the Rx partners will be too happy about sharing the spoils for long.
Bruh we are in a dogshit market and you just named the two RX shops that are leagues better than anyone else lmao. Of course they are hiring
the vast majority of hiring has been in M&A
I think M&A deal activity has been recovering fast, wait for these Q3/Q4 numbers. Disney / Hulu, Chevron, Activision closing and a few more
It’s smart of them and will pay off in long run assuming market comes back.
As others have said, both have the RX practice to help fund this. EVR also is just a more diversified firm (have the big S&T business) so easier to spend money in a bad year. The entire point of having RX and M&A together is to balance cycles - M&A teams have been funneling bonus money to RX teams for the last few years, now it’s the RX teams turn to float the ship. Bitter RX analysts can MS me but you’ve been getting paid out of the M&A fee pool since 2020.
It’s also cheaper than ever to hire good seniors, most banks won’t be able to pay much this year (look at all the BB earnings, all the M&A heavy places getting killed, etc) so you can poach someone for a relatively good guarantee vs what they would make but probably a number that would normally seem cheap.
If the market comes back in the next 1-3 years, the banks that are hiring now will crush it in the next cycle. If it’s a sustained downturn this obviously hurts the bonus pool, but I think the assumption is M&A has to come back in some capacity once PE funds start aging and it’s time to sell even if valuations aren’t fully back.
Some banks did this in ‘08 and it’s what has shaped what banks are strong today vs weaker.
Only thing that surprises me is that BBs aren’t as aggressive - clearly they’re trying to de-risk to IB vs doubling down, but it probably will only accelerate the shift towards EBs in the long run
I can’t speak to all firms, but Rx is typically higher revenue per headcount than M&A and that was even almost true in 2021.
Houlihan is the only firm you can actually do the math on this from public filings since they break out Rx from M&A.
Consequatur non quia occaecati odio corrupti consequuntur ex. Saepe reiciendis aut dicta repellendus. Omnis reiciendis vitae ratione. Repellat eaque sed itaque dolorum et in.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...